Skip to main content
Tech.euFundingExplorerBeta

Thriva

Home blood tests developer company

Thriva has raised €14M across 4 funding rounds from 10 investors, most recently a Series A round in May 2020. Based in London, UK; active in Healthtech. Data as of 4 Nov 2026.

Total raised
€14M
€14,421,431
Funding rounds
4
Investors
10
distinct backers
Active since
2017-06
latest 2020-05

Funding by year

EUR raised per year
Thriva — funding by year — interactive chart.
Data table
Thriva — funding by year
2017€3.3M
2019€6.7M
2020€4.4M

Signals

High confidence
Raise-next likelihood8
base rate 44% for Series A
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▼ Down/flat last round
Exit likelihood11
base rate 11% (2+ rounds)
  • ▲ 4 rounds raised
  • ▲ 9y since founding (typical exit age)
  • ▼ No recent equity round (debt-only or quiet)

Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.

Similar companies

same sector, similar size

Global coverage: FundingData